| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |